Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

SELL
$0.68 - $1.49 $18,101 - $39,663
-26,620 Reduced 13.89%
165,095 $139,000
Q1 2022

May 12, 2022

BUY
$1.07 - $3.36 $184,206 - $578,444
172,156 Added 880.19%
191,715 $300,000
Q4 2021

Feb 10, 2022

BUY
$1.33 - $4.09 $1,246 - $3,832
937 Added 5.03%
19,559 $65,000
Q3 2021

Nov 09, 2021

SELL
$1.82 - $3.2 $575 - $1,011
-316 Reduced 1.67%
18,622 $38,000
Q2 2021

Aug 11, 2021

BUY
$2.87 - $4.11 $54,352 - $77,835
18,938 New
18,938 $59,000

About Petros Pharmaceuticals, Inc.


  • Ticker PTPI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 20,708,000
  • Market Cap $5.18M
  • Description
  • Petros Pharmaceuticals, Inc., a pharmaceutical company, focuses on men's health therapeutics. The company engages in the commercialization and development of Stendra, an PDE-5 inhibitor prescription medication for the treatment of erectile dysfunction (ED). It also develops and commercializes H100, a patented topical formulation candidate for th...
More about PTPI
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.